Crescita Therapeutics (TSX:CTX) Other Long Term Assets : C$1.90 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Crescita Therapeutics Other Long Term Assets?

Crescita Therapeutics's other long-term assets for the quarter that ended in Mar. 2024 was C$1.90 Mil.

Crescita Therapeutics's quarterly other long-term assets declined from Sep. 2023 (C$2.12 Mil) to Dec. 2023 (C$1.91 Mil) but then stayed the same from Dec. 2023 (C$1.91 Mil) to Mar. 2024 (C$1.90 Mil).

Crescita Therapeutics's annual other long-term assets increased from Dec. 2021 (C$2.18 Mil) to Dec. 2022 (C$2.45 Mil) but then declined from Dec. 2022 (C$2.45 Mil) to Dec. 2023 (C$1.91 Mil).

Crescita Therapeutics Other Long Term Assets Historical Data

The historical data trend for Crescita Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crescita Therapeutics Other Long Term Assets Chart

Crescita Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

2.16

1.98

2.18

2.45

1.91

Crescita Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															2.29	2.14	2.12	1.91	1.90

Crescita Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Crescita Therapeutics (TSX:CTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Crescita Therapeutics Inc (TSX:CTX) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

CRRTF:USA

Address

2805, Place Louis-R-Renaud, Laval, QC, CAN, H7V 0A3

Website

https://www.crescitatherapeutics.com

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue in the form of product sales and out-licensing revenue.

Executives

Knight Therapeutics Inc.

10% Security Holder

Crescita Therapeutics (TSX:CTX) Headlines

No Headlines